Cardinal HealthCAH +0.82%81 EV-to-FCF is 13.72 as of Jun. 25, 2026, which is 19% above its 10-year median of 11.53. GuruFocus rates CAH with a GF Score™ of 81/100 and a GF Value™ of $141.44 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 76 Medical Distribution companies, Cardinal Health ranks better than 59.21% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cardinal Health's Enterprise Value is $60,161 Mil.
Cardinal Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $4,385 Mil. Therefore, Cardinal Health's EV-to-FCF for today is 13.72.
The historical rank and industry rank for Cardinal Health's EV-to-FCF or its related term are showing as below:
CAH'
s EV-to-FCF Range Over the Past 10 Years
Min: -76.81 Med: 11.53 Max: 48.32
Current: 13.72
During the past 13 years, the highest EV-to-FCF of Cardinal Health was 48.32. The lowest was -76.81. And the median was 11.53.
CAH's EV-to-FCF is ranked better than 59.21% of 76
companies
in the Medical Distribution industry
Industry Median: 16.535
vs CAH: 13.72
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cardinal Health's PE Ratio (TTM) for today is calculated as:
Cardinal Health's share price for today is $234.93.
Cardinal Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.540.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Cardinal Health EV-to-FCF Related Terms
Cardinal Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Cardinal Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Cardinal Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardinal Health EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cardinal Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Cardinal Health's EV-to-FCF falls into.
Cardinal Health's current Enterprise Value is $60,161 Mil.
Cardinal Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,385 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardinal Health (CAH) has a EV-to-FCF of 13.72 as of Jun. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cardinal Health and its competitors. This is 19% above median its historical median of 11.53. According to the industry distribution chart, Cardinal Health ranks #31 out of 76 companies in the Medical Distribution industry, placing it in the top 40.8%.
Is Cardinal Health's EV-to-FCF too high?
Cardinal Health's current EV-to-FCF of 13.72 is 19% above median its 10-year median of 11.53. The Medical Distribution industry median EV-to-FCF is 16.54. Cardinal Health's value of 13.72 is 17% below this industry median. Based on the distribution chart, Cardinal Health ranks #31 out of 76 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Cardinal Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's EV-to-FCF compare to COR and HSIC?
According to the Medical Distribution industry distribution chart, Cardinal Health ranks #31 out of 76 companies for EV-to-FCF. This puts Cardinal Health in the upper half of its industry. The industry median EV-to-FCF is 16.54. Cardinal Health's value of 13.72 is 17% below this benchmark. While the company's 10-year median is 11.53 vs. the industry median of 16.54, Cardinal Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.54, based on 76 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cardinal Health's current EV-to-FCF of 13.72 is 17% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cardinal Health and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardinal Health's current EV-to-FCF is 13.72, which is 19% above median its own 10-year median of 11.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (CAH) is currently considered Significantly Overvalued. The stock's GF Value™ is $141.44, compared to a current price of $234.93 — trading 66.1% above its estimated fair value. The current EV-to-FCF is 13.72, which is 19% above median its 10-year median of 11.53 and 17% below the Medical Distribution industry median of 16.54. Cardinal Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Cardinal Health (CAH), the current EV-to-FCF is 13.72 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardinal Health (CAH) Overvalued in 2026?
Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued.
The current stock price of $234.93 is trading 66.1% above its estimated GF Value™ of $141.44.
GuruFocus considers Cardinal Health to be Significantly Overvalued.
Key valuation signals for CAH:
EV-to-FCF: 13.72 (19% above median its 10-year median of 11.53)
GF Value™: $141.44 vs. price of $234.93 (66.1% above fair value)
Industry Position: 17% below the Medical Distribution median (#31 of 76)
No single metric tells the full story. See the CAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
81GF Score
Get the complete analysis for CAH
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAH has been successfully added to your 
